Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Notably, it can lead to a false-positive pregnancy test due to its molecular similarity to endogenous pregnancy HCG, which is the target of standard hCG immunoassays
Why this trial matters: First global Phase III success in a disease with no approved targeted therapy Could change management of systemic symptoms and glandular dysfunction Gene Therapy Phase III in Epidermolysis Bullosa Shows Healing Benefit A Phase III gene therapy trial for epidermolysis bullosa (EB) demonstrated significantly better wound healing, less pain, and reduced itching compared with standard care, and the therapy earned FDA approval in 2025 a major advance for this previously untreatable genetic skin disorder
Before every injection at Southdowns, our pharmacist goes through a health check with you first
Neurosci Lett
US$ 22.97
US$ 29.45
US$ 22.49
